Beneficiary Advocates Blast CMS For Shifting Drug Formulary/Cost-Sharing Reviews To States

Beneficiary advocates are upset by CMS' move to stop reviewing drug formularies as part of the Qualified Health Plan (QHP) certification process for federally facilitate marketplace states that conduct plan management, arguing that punting to the states could weaken patient protections. The advocates note that CMS initially took on the job because plans were limiting coverage, charging high patient cost-sharing, and discriminating against patients with serious and chronic health conditions. One advocacy group has already requested a meeting with the...